Earnings Report /

Hyphens Pharma International Ltd: Digital healthcare catalyst emerges

  • Raised $6mn for a 10% stake in Hyphens Pharma digital assets – DocMed Technology

  • DocMed Technology owns POM (B2B digital hypermart) and WellAway (Singapore’s first and only HSA registered e-pharmacy).

  • Our DCF target price is raised from S$0.345 to S$0.43

Paul Chew
Paul Chew

Head of Research

6 June 2022
Published byPhillipCapital


Tellimer | Start Following

Start following your markets today

Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.